228
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 418-424 | Received 04 Jun 2021, Accepted 30 Dec 2021, Published online: 13 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tudor Rares Olariu, Rodica Lighezan, Sorin Ursoniu, Alina Cristiana Craciun, Alin Gabriel Mihu & Maria Alina Lupu. (2022) High SARS-CoV-2 seroprevalence in blood donors from Romania after the third COVID-19 pandemic wave. Infectious Diseases 54:7, pages 534-537.
Read now

Articles from other publishers (9)

Irina Kislaya, Pedro Casaca, Vítor Borges, Carlos Sousa, Bibiana I. Ferreira, Ana Fonte, Eugénia Fernandes, Carlos Matias Dias, Sílvia Duarte, José Pedro Almeida, Inês Grenho, Luís Coelho, Rita Ferreira, Patrícia Pita Ferreira, Cláudia Medeiros Borges, Joana Isidro, Miguel Pinto, Luís Menezes, Daniel Sobral, Alexandra Nunes, Daniela Santos, António Maia Gonçalves, Luís Vieira, João Paulo Gomes, Pedro Pinto Leite, Baltazar Nunes, Ausenda Machado & André Peralta-Santos. (2023) Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal. Emerging Infectious Diseases 29:3, pages 569-575.
Crossref
Irina Kislaya, Aryse Melo, Marta Barreto, Camila Henriques, Carlos Aniceto, Carla Manita, Sara Ramalhete, João Almeida Santos, Sofia Soeiro & Ana Paula Rodrigues. (2023) Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022. Emerging Infectious Diseases 29:3, pages 590-594.
Crossref
Lara E. Coelho, Paula M. Luz, Débora C. Pires, Emilia M. Jalil, Hugo Perazzo, Thiago S. Torres, Sandra W. Cardoso, Eduardo M. Peixoto, Sandro Nazer, Eduardo Massad, Mariângela F. Silveira, Fernando C. Barros, Ana T.R. Vasconcelos, Carlos A.M. Costa, Rodrigo T. Amancio, Daniel A.M. Villela, Tiago Pereira, Guilherme T. Goedert, Cleber V.B.D. Santos, Nadia C.P. Rodrigues, Beatriz Grinsztejn, Valdilea G. Veloso & Claudio J. Struchiner. (2022) Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey. The Lancet Regional Health - Americas 15, pages 100338.
Crossref
Irina Kislaya, Paulo Gonçalves, Sara Ramalhete, Marta Barreto, Ana Rita Torres, Vânia Gaio, Verónica Gómez, Carla Manita, João Almeida Santos, Sofia Soeiro, Rita De Sousa, Aryse Melo, Camila Henriques, Raquel Guiomar, Ana Paula Rodrigues & On Behalf of ISNCOVID-19 Group. (2022) SARS-CoV-2 Seroprevalence Following a Large-Scale Vaccination Campaign in Portugal: Results of the National Serological Survey, September - November 2021. Acta Médica Portuguesa 36:1, pages 5-14.
Crossref
Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien & Steven J. Drews. (2022) Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Microbiology Spectrum 10:5.
Crossref
Aliisa Heiskanen, Yannick Galipeau, Marc-André Langlois, Julian Little & Curtis L. Cooper. (2022) SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review. International Journal of Environmental Research and Public Health 19:18, pages 11629.
Crossref
Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Ninette F. Robbins, Guillermo Orjuela, Craig Jenkins, Valerie Conrod, Qi-Long Yi, Sheila F. O’Brien & Steven J. Drews. (2022) A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021. Microbiology Spectrum 10:3.
Crossref
Stefania Paduano, Pasquale Galante, Nausicaa Berselli, Luca Ugolotti, Alberto Modenese, Alessandro Poggi, Marcella Malavolti, Sara Turchi, Isabella Marchesi, Roberto Vivoli, Paola Perlini, Rossana Bellucci, Fabriziomaria Gobba, Marco Vinceti, Tommaso Filippini & Annalisa Bargellini. (2022) Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy. International Journal of Environmental Research and Public Health 19:13, pages 7882.
Crossref
Irina Kislaya, Pedro Casaca, Vítor Borges, Carlos Sousa, Bibiana I. Ferreira, Ana Fonte, Eugenia Fernandes, Carlos Matias Dias, Silvia Duarte, José Pedro Almeida, Inês Grenho, Luís Coelho, Rita Ferreira, Patrícia Pita Ferreira, Cláudia Medeiros Borges, Joana Isidro, Miguel Pinto, Luís Menezes, Daniel Sobral, Alexandra Nunes, Daniela Santos, António Maia Gonçalves, Luís Vieira, João Paulo Gomes, Pedro Pinto Leite, Baltazar Nunes, Ausenda Machado & André Peralta-Santos. (2022) Comparative COVID-19 Vaccines Effectiveness in Preventing Infections, Hospitalizations, and Deaths with SARS-CoV-2 BA.5 and Ba.2 Omicron Lineages: A Case-Case and Cohort Study Using Electronic Health Records in Portugal. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.